Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7XJQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $189,505
Award facts
- Contract value 100% obligated
- $189,504.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for Dupixent 300 mg/2 ml syringes with a ceiling value of $189,504.78. Place of performance is Conshohocken, PA. Ultimate completion date is April 23, 2026. This is a firm fixed-price delivery order with no set-aside used.
Quick answers
Who was awarded contract SPE2DR26F7XJQ?
SPE2DR26F7XJQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 22, 2026.
How much is contract SPE2DR26F7XJQ worth?
The government has obligated $189,505 on SPE2DR26F7XJQ.
Is contract SPE2DR26F7XJQ an order under another contract?
Yes. SPE2DR26F7XJQ is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7XJQ competed?
The extent of competition for SPE2DR26F7XJQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award